AstraZeneca's vaccine study put on hold
Nicolas Suiffet September 9, 2020 5:48 PM
AstraZeneca's, a pharmaceutical group, Covid-19 vaccine phase 3 trial has been put on hold due to a suspected serious adverse reaction in a participant in the U.K
AstraZeneca's Covid-19 vaccine phase 3 trial has been put on hold due to a suspected serious adverse reaction in a participant in the U.K., according to the Stat News.
From a chartist point of view, the stock price remains in consolidation mode below the key resistance threshold at 8736p. A morning star pattern has formed but the signal still needs to be confirmed. The daily Relative Strength Index (RSI, 14) is reversing up but remains below 50% and remains capped by a declining trend line. The 20/50DMAs still play a resistance role. As long as 8736p is resistance, the risk of a break below the swing low at 7930p will remain high. Alternatively, a push above 8736p would reinstate a bullish bias with 9350p as first target.
Source: GAIN Capital, TradingView
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.